Pulmonary Disease Doctors in Joplin, MO Accepting Medicare

5 Pulmonary Disease doctors found. Showing 1 - 5

Festus A Ndukwu, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2727 E 32nd St, Ste 3, Joplin, MO 64804 Phone: 417-717-0410    Fax: 417-717-0408

Syed A. Ahmed, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Mercy Way, Suite 450, Joplin, MO 64804 Phone: 417-556-8377    Fax: 417-556-8378

Dr. Waqas A Chishti, MBBS Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1111 Mcintosh Cir, Suite 302, Joplin, MO 64804 Phone: 417-347-8315

Adnan Khan, M.D Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1102 W 32nd St, Joplin, MO 64804 Phone: 417-347-4570

Dr. Toufic Tony Saad, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3020 Saint Johns Blvd, Ste B, Joplin, MO 64804 Phone: 417-627-8377    Fax: 417-627-8378

News Archive

Exposure to mobile phone derived electromagnetic fields can influence learning processes

High frequency non-ionizing radiation, emitted by mobile phones, is redundantly matter of discussions. The effects of high frequency electromagnetic fields derived from mobile phones have been discussed since the 1950's.

New type of surgery can help amputees better control their residual muscles

MIT researchers have invented a new type of amputation surgery that can help amputees to better control their residual muscles and sense where their "phantom limb" is in space.

New evidence supports thrombolysis in presence of contraindications

A Norwegian study offers further evidence to support the use of intravenous thrombolysis to treat stroke even in patients with contraindications to the drug.

Marqibo now available to leukemia patients through myTomorrows' Internet-based platform

myTomorrows (Amsterdam, the Netherlands), announced today that it has started a collaboration with Spectrum Pharmaceuticals, Inc. (Henderson, USA) to provide access to its liposome-encapsulated vincristine for treatment of Philadelphia chromosome negative acute lymphoblastic leukemia.

First U.S. outpatient trial of UVA-developed artificial pancreas

The University of Virginia School of Medicine has launched the first U.S. outpatient trial of a UVA-developed artificial pancreas that could make it easier for type 1 diabetes patients to manage their condition.

Read more Medical News

› Verified 4 days ago